Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China flag China · Delayed Price · Currency is CNY
17.86
+0.20 (1.13%)
Feb 3, 2026, 2:55 PM CST

SHA:603456 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,7122,7493,2061,0951,121324.57
Trading Asset Securities
----26.0627.45
Cash & Short-Term Investments
2,7122,7493,2061,0951,147352.03
Cash Growth
1.70%-14.27%192.71%-4.49%225.79%-37.71%
Accounts Receivable
1,0651,255997.69767.03850.02691.24
Other Receivables
19.5511.88.326.465.728.52
Receivables
1,0851,2661,006773.49855.74699.77
Inventory
1,5821,9291,9592,0211,6821,170
Other Current Assets
140.63127.5142.55102.8787.3873.69
Total Current Assets
5,5196,0716,3143,9933,7722,295
Property, Plant & Equipment
4,3344,2743,7223,1442,6452,321
Long-Term Investments
202.37108.08121.88109.13101.0729.87
Goodwill
87.8888.6110.11111.1170.3575.07
Other Intangible Assets
500.29516.11504.74454.03412.47235.78
Long-Term Deferred Tax Assets
1.891.680.7524.4311.217.58
Long-Term Deferred Charges
73.8364.7673.269.0716.210.14
Other Long-Term Assets
-2.94.748.3812.1536.54
Total Assets
10,71911,12710,8527,9147,0405,002
Accounts Payable
1,1021,4591,1981,245988.14530.25
Accrued Expenses
147.44202.63227.81201.85168.05149.82
Short-Term Debt
122.36--50.05498.84788.02
Current Portion of Long-Term Debt
6.25201.937.77200.21-10.01
Current Portion of Leases
-7.796.786.591.01-
Current Income Taxes Payable
104.6855.7455.378.875.3726.86
Current Unearned Revenue
102.0469.7575.4183.0849.6422.76
Other Current Liabilities
41.9649.8485.95348.37303.65105.32
Total Current Liabilities
1,6272,0461,6572,2142,0851,633
Long-Term Debt
-194.25389.0583.99201.49140.19
Long-Term Leases
7.878.0311.8910.63.25-
Long-Term Unearned Revenue
151.06139.89109.12101.297.3192.49
Long-Term Deferred Tax Liabilities
83.9487.47101.47106.2676.5549.95
Other Long-Term Liabilities
25.141.7650.7725.76--
Total Liabilities
1,8952,5182,3192,5422,4631,916
Common Stock
889.45895.24899.49834.25832.6805.23
Additional Paid-In Capital
4,2854,3804,4992,0581,985971.34
Retained Earnings
3,6573,3503,1902,5151,8021,335
Treasury Stock
-102-99.9-132.01-113.12-44.43-30.66
Comprehensive Income & Other
25.2311.524.652.261.492.54
Total Common Equity
8,7558,5378,4615,2974,5773,083
Minority Interest
69.0372.9171.9475.1-2.91
Shareholders' Equity
8,8248,6108,5335,3724,5773,086
Total Liabilities & Equity
10,71911,12710,8527,9147,0405,002
Total Debt
136.48412415.49351.44704.58938.22
Net Cash (Debt)
2,5752,3372,791743.98442.29-586.2
Net Cash Growth
18.92%-16.27%275.13%68.21%--
Net Cash Per Share
2.922.623.130.900.53-0.72
Filing Date Shares Outstanding
887.71889.45899.49834.25832.6831.41
Total Common Shares Outstanding
887.71889.45899.49834.25832.6805.23
Working Capital
3,8924,0254,6581,7791,687662.34
Book Value Per Share
9.869.609.416.355.503.83
Tangible Book Value
8,1677,9327,8464,7324,0942,772
Tangible Book Value Per Share
9.208.928.725.674.923.44
Buildings
-1,9661,7861,6121,5621,354
Machinery
-4,6654,3504,0103,6843,326
Construction In Progress
-1,5661,198839.25471.51300.08
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.